Cisco Stock Is Climbing, And It Is Not About Covid-19 Vaccine - Time To Get In?

Cisco's stock jumped more than 11% during the last 5 trading days. In comparison, the S&P 500 climbed nearly 2.3%. While most stocks benefited from vaccine announcements from Pfizer and Moderna, Cisco has its own story. And that story is that Cisco's exposure to legacy and on-premise IT spending...